| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.055 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |